Pontifax Venture Capital — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Mereo BioPharma is a biopharmaceutical company that develops novel therapies for rare diseases with limited or no treatment options, focusing on lead programs in osteogenesis imperfecta (OI) and Alpha-1 Antitrypsin Deficiency-associated Lung Disease (AATD-LD).
BiotechLondon
John Richard(Head of Corporate Development and Co-Founder)Dr. Denise Scots-Knight(Chief Executive Officer and Co-Founder)Charles Sermon(General Counsel and Co-Founder)Richard Jones(Chief Financial Officer)Jill Henrich(Senior Vice President)
BoardDr. Deepa Pakianathan(Non-Executive Director)
Co-investorsVivo Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.